Oenon Holdings, Inc. develops alcoholic beverages, food products, enzymes and pharmaceuticals, real estate, and other businesses based on biotechnologies derived from fermentation technologies in Japan. The company offers alcoholic beverages, including shochu, chu-hi, sake, sake compounds, umeshu plum wine, processed liquor, wine, brewing and industrial alcohol, seasonings, and other products. It also manufacture and sell enzymes for food and industrial use comprising lactase, a lactose hydrolytic enzyme; cellulase, a dietary fiber processing enzyme; glucose isomelase, a fructose corn syrup manufacturing enzyme; protease, a proteolytic enzyme; dispase, a cell dispersion enzyme; and isoamylase, a starch processing enzyme. In addition, the company offers active pharmaceutical ingredients, such as Pravastatin for hyperlipidemia treatment; Voglibose for diabetes mellitus treatment; starch for food processing; and diagnostic medicines and health foods. Further, it sells and leases real estate properties. Additionally, the company engages in transportation and cargo handling, and other activities. Oenon Holdings, Inc. was incorporated in 1920 and is headquartered in Tokyo, Japan.